Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Attributable risk estimate of severe psoriasis on major cardiovascular events.

Mehta NN, Yu Y, Pinnelas R, Krishnamoorthy P, Shin DB, Troxel AB, Gelfand JM.

Am J Med. 2011 Aug;124(8):775.e1-6. doi: 10.1016/j.amjmed.2011.03.028.

2.

Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database.

Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM.

Eur Heart J. 2010 Apr;31(8):1000-6. doi: 10.1093/eurheartj/ehp567. Epub 2009 Dec 27.

3.

Prevalence of cardiovascular risk factors in patients with psoriasis.

Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM.

J Am Acad Dermatol. 2006 Nov;55(5):829-35. Epub 2006 Sep 25.

PMID:
17052489
4.

Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies.

Armstrong EJ, Harskamp CT, Armstrong AW.

J Am Heart Assoc. 2013 Apr 4;2(2):e000062. doi: 10.1161/JAHA.113.000062. Review.

5.

Prognosis following first-time myocardial infarction in patients with psoriasis: a Danish nationwide cohort study.

Ahlehoff O, Gislason GH, Lindhardsen J, Olesen JB, Charlot M, Skov L, Torp-Pedersen C, Hansen PR.

J Intern Med. 2011 Sep;270(3):237-44. doi: 10.1111/j.1365-2796.2011.02368.x. Epub 2011 Mar 24.

6.

Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis.

Kaye JA, Li L, Jick SS.

Br J Dermatol. 2008 Sep;159(4):895-902. doi: 10.1111/j.1365-2133.2008.08707.x. Epub 2008 Jul 4.

PMID:
18616778
7.

Risk of myocardial infarction in patients with psoriasis.

Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB.

JAMA. 2006 Oct 11;296(14):1735-41.

PMID:
17032986
8.

Psoriasis and the Risk of Major Cardiovascular Events: Cohort Study Using the Clinical Practice Research Datalink.

Parisi R, Rutter MK, Lunt M, Young HS, Symmons DP, Griffiths CE, Ashcroft DM; Identification and Management of Psoriasis Associated ComorbidiTy (IMPACT) project team.

J Invest Dermatol. 2015 Sep;135(9):2189-97. doi: 10.1038/jid.2015.87. Epub 2015 Mar 5.

PMID:
25742120
9.

The risk of stroke in patients with psoriasis.

Gelfand JM, Dommasch ED, Shin DB, Azfar RS, Kurd SK, Wang X, Troxel AB.

J Invest Dermatol. 2009 Oct;129(10):2411-8. doi: 10.1038/jid.2009.112. Epub 2009 May 21.

10.

Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review.

Horreau C, Pouplard C, Brenaut E, Barnetche T, Misery L, Cribier B, Jullien D, Aractingi S, Aubin F, Joly P, Le MaƮtre M, Ortonne JP, Paul C, Richard MA.

J Eur Acad Dermatol Venereol. 2013 Aug;27 Suppl 3:12-29. doi: 10.1111/jdv.12163. Review.

PMID:
23845149
11.

Disease severity and therapy as predictors of cardiovascular risk in psoriasis: a population-based cohort study.

Maradit-Kremers H, Icen M, Ernste FC, Dierkhising RA, McEvoy MT.

J Eur Acad Dermatol Venereol. 2012 Mar;26(3):336-43. doi: 10.1111/j.1468-3083.2011.04071.x.

12.

Risk and predictors of cardiovascular disease in psoriasis: a population-based study.

Maradit-Kremers H, Dierkhising RA, Crowson CS, Icen M, Ernste FC, McEvoy MT.

Int J Dermatol. 2013 Jan;52(1):32-40. doi: 10.1111/j.1365-4632.2011.05430.x.

13.

Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis.

Brauchli YB, Jick SS, Miret M, Meier CR.

Br J Dermatol. 2009 May;160(5):1048-56. doi: 10.1111/j.1365-2133.2008.09020.x. Epub 2009 Feb 4.

PMID:
19210501
14.

Increased risk of arrhythmia in patients with psoriatic disease: A nationwide population-based matched cohort study.

Chiu HY, Chang WL, Huang WF, Wen YW, Tsai YW, Tsai TF.

J Am Acad Dermatol. 2015 Sep;73(3):429-38. doi: 10.1016/j.jaad.2015.06.023. Epub 2015 Jul 15.

PMID:
26188627
15.

Psoriasis and risk of heart failure: a nationwide cohort study.

Khalid U, Ahlehoff O, Gislason GH, Kristensen SL, Skov L, Torp-Pedersen C, Hansen PR.

Eur J Heart Fail. 2014 Jul;16(7):743-8. doi: 10.1002/ejhf.113. Epub 2014 Jun 5.

16.

Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies.

Reich K, Langley RG, Lebwohl M, Szapary P, Guzzo C, Yeilding N, Li S, Hsu MC, Griffiths CE.

Br J Dermatol. 2011 Apr;164(4):862-72. doi: 10.1111/j.1365-2133.2011.10257.x.

PMID:
21332467
17.

Usefulness of the framingham risk score in patients with chronic psoriasis.

Gisondi P, Farina S, Giordano MV, Girolomoni G.

Am J Cardiol. 2010 Dec 15;106(12):1754-7. doi: 10.1016/j.amjcard.2010.08.016. Epub 2010 Nov 4.

PMID:
21055711
18.

High prevalence of cardiovascular risk factors in patients with moderate or severe psoriasis in northern China.

Ma L, Li M, Wang H, Li Y, Bai B.

Arch Dermatol Res. 2014 Apr;306(3):247-51. doi: 10.1007/s00403-013-1437-3. Epub 2014 Jan 3.

PMID:
24385235
19.

Prevalence of myocardial infarction in patients with psoriasis in central China.

Xiao J, Chen LH, Tu YT, Deng XH, Tao J.

J Eur Acad Dermatol Venereol. 2009 Nov;23(11):1311-5. doi: 10.1111/j.1468-3083.2009.03318.x. Epub 2009 Jun 1.

PMID:
19522710
20.

The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study.

Abuabara K, Lee H, Kimball AB.

Br J Dermatol. 2011 Nov;165(5):1066-73. doi: 10.1111/j.1365-2133.2011.10525.x.

PMID:
21777216
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk